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Cervical cancer is the second most common malig-
nant disease among women worldwide, and is the
principal cancer among women in most developing
countries [1]. Although it has been considered to be 
a preventable cancer because of a long preinvasive
state, cervical intraepithelial neoplasia (CIN) [2], the
underlying mechanisms of cervical carcinogenesis
remain an important issue.
Signal transducer and activator of transcription
(STAT) proteins comprise a family of transcription
factors latent in the cytoplasm that consists of seven
different members: STAT1, 2, 3, 4, 5A, 5B, and 6 [3].
These transcription factors are activated by a series of
extracellular signaling proteins such as cytokines,
growth factors, and hormones that bind to specific
cell-surface receptors, and are consequently phospho-
rylated to form homo- or heterodimers allowing their
translocation to the nucleus to influence different
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Signal transducer and activator of transcription 3 (STAT3) has been regarded as an oncogene in
many types of cancers. However, its role in cervical carcinogenesis is not well determined. The
purpose of this study was to evaluate the expression patterns of STAT3 in cervical intraepithelial
neoplasia (CIN), normal cervix (NC), and squamous cell carcinoma (SCC) to explore its possible
role in cervical carcinogenesis. Paraffin-embedded sections from 83 patients including 20 CIN 1,
10 CIN 2, 26 CIN 3, and 27 comparative cases of 10 NC and 17 stage Ib SCC were collected in this
study. Immunohistochemistry was performed to analyze the expression patterns of STAT3, and
the results obtained were categorized by a semiquantitative method and were further correlated
with the CIN histopathologic grade and the proliferation marker, Ki-67, using the χ2 test. Our
results showed that nuclear STAT3 expression was predominantly in the squamous epithelial
cells, and that high-grade CIN and stage Ib SCC lesions had a higher nuclear STAT3 expression
when compared with NC and CIN 1. Furthermore, the nuclear STAT3 expression in CIN was sig-
nificantly correlated with Ki-67 expression (p = 0.025), but not CIN lesion grade. In summary, our
results indicate that an altered STAT3 expression in CIN is correlated with cell proliferation but
may not have a direct contribution to cervical carcinogenesis. 
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normal physiologic cell processes including prolifer-
ation, differentiation, apoptosis, and angiogenesis [4],
and also various pathologic events, such as cell
transformation and oncogenesis [5]. Among these
STAT family members, STAT3 is more often consid-
ered to be an oncogene [6] because STAT3 knockout
mice die early in embryogenesis [7]. In addition, 
constitutively activated STAT3 is observed in a wide
range of human cancer cell lines and primary tumors,
including carcinoma of the head and neck [8], ovary
[9], prostate [10], breast [11], etc. Although accumu-
lating evidence shows that STAT3 pathway may con-
tribute to cervical tumorigenesis [12,13], the potential
role of STAT3 in the development of cervical cancer is
not clinically established.
Ki-67 antigen is a nuclear protein, which is tightly
associated with somatic cell proliferation [14]. Detailed
cell cycle analyses have revealed that this antigen is
expressed in all active phases of the cell cycle (G1, S,
G2/M) but not in the resting phase (Go) [15,16], indi-
cating that the Ki-67 antigen could be used as a marker
for cells of the “growth fraction”. In many cancers,
antibodies against the human Ki-67 protein pave the
way for the immunohistochemical assessment of cell
proliferation [17]. In CIN lesions, Ki-67 labeling index
in basal and parabasal layers of the cervix shows a pro-
gressive rise with increasing grade, suggesting that Ki-
67 immunoquantitation is a sensitive biologic indicator
of progression of seemingly low-grade CIN [18,19].
In the present study, we focused on examining the
expression patterns of the activated form of STAT3,
usually expressed in the nucleus, CIN lesions, normal
cervix (NC), and cervical squamous cell carcinoma
(SCC), and correlated the results with promising
parameters to assess the potential role of STAT3 in
cervical carcinogenesis.
MATERIALS AND METHODS
Surgical specimens
Between January 1996 and December 2002, 120 tissue
samples of CIN were obtained from the Department
of Pathology, Kaohsiung Medical University Hospital.
For the purpose of this study, 56 CIN cases (mean
age, 45.9 ± 11.8 years; range, 21–86 years) undergo-
ing loop electroexcision procedure with free surgi-
cal margin were identified. In addition, another 10
cases with normal cervical tissue retrieved by total
hysterectomy for uterine leiomyomas, and 17 cases
with International Federation of Gynecology and
Obstetrics (FIGO) [20,21] stage Ib FIGO grade 2 SCC
receiving radical hysterectomy without vascular inva-
sion and metastases were chosen for comparison with
the CIN cases. According to the WHO grading histo-
pathologic classification [22], the 56 CIN cases were
divided into three groups: 20 CIN 1, 10 CIN 2, and 
26 CIN 3 cases. All the patients were followed up 
for 24–94 months, and remained free of persistent 
or recurrent lesions. Each tissue specimen was rou-
tinely embedded in paraffin wax after 10% formalin
fixation, and cut into several 3 μm thick sections for
conventional hematoxylin and eosin staining and
immunostaining. For accurate histopathologic diag-
nosis, repeated confirmations were made by two gyne-
cologic pathologists.
Immunohistochemistry
Three micrometer thick sections from representative
tissue blocks were cut, deparaffinized with xylene rinse
and rehydrated into distilled H2O through graded
alcohol. Antigen retrieval was enhanced by autoclaving
slides in sodium citrate buffer (pH 6.0) for 15 minutes.
Endogenous peroxidase activity was quenched by 10
minutes of incubation in a 3% hydrogen peroxide/
methanol buffer. The slides were then incubated with
primary rabbit polyclonal STAT3 antibody (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA) at a dilution
of 1:200 for 1 hour at room temperature. Slides were
washed three times in phosphate buffer solution and
further incubated with a biotinylated secondary anti-
body for 20 minutes at room temperature. Antigen–
antibody complexes were detected by the avidin-biotin-
peroxidase method using diaminobenzidine as a
chromogenic substrate (DAKO Corp., Carpinteria, CA,
USA). Finally, the slides were counterstained with
hematoxylin and then examined by light microscopy.
Ki-67 expression was assessed using purified antihu-
man monoclonal antibody (1:75; DAKO).
Evaluation of immunohistochemical
staining
The percentage of immunoreactive dysplastic cells
for STAT3 and Ki-67 was graded by a four-tiered
semiquantitative system: Score 1, ≤ 25% positive cells;
Score 2, 26–50% positive cells; Score 3, 51–75% posi-
tive cells; and Score 4, ≥ 76% positive cells (Figure 1).
More than 1,000 cells expressed in three to four 
different high-power field areas were analyzed for
each sample. Sections of breast cancer tissue were
used as a positive control for STAT3 immunostain-
ing, while sections of tonsil tissue were used as a 
positive control for Ki-67 immunostaining. Negative
controls were obtained by substituting the primary
antibody with the immunoglobulin fraction of non-
immune rabbit serum (for STAT3) and nonimmune
mouse serum (for Ki-67). The immunostaining was
determined for each specimen, estimated by two
independent pathologists. The rare cases with discor-
dant scores were reevaluated and scored on the basis
of the consensual opinion.
Statistical analysis
STAT3 and Ki-67 staining statuses were classified as
low (Scores ≤ 2) or high (Scores >2) expression before
statistical evaluation. All analyses were performed
using SPSS version 10.0 (SPSS Inc., Chicago, IL, USA).
The correlation of STAT3 expression with the histo-
pathologic grading of CIN and with Ki-67 expression
was analyzed using the χ2 test. A p value of less than
0.05 was considered to be statistically significant.
RESULTS
Expression patterns of STAT3 and 
Ki-67 in CIN, NC, and SCC
The results from the immunohistochemical analysis
are summarized in Table 1. The expression of STAT3
was predominantly present in the nucleus of squa-
mous epithelium and leukocytes, and focally present
in the cytoplasm of keratinocytes, leukocytes, and
parenchymal cells (Figure 1A–D). In comparison
with the adjacent normal epithelium and NC (Figure
3F), the nuclear expression of STAT3 was increased 
in CIN (Figures 2A, B and 3G–I) and SCC lesions
(Figure 3J). In addition, a strong immunostaining
(Score 4) of STAT3 was observed in 42.3% of CIN 3
cases and 23.5% of SCC cases, but was not observed
in any comparative NC and CIN 1 cases (Table 1).
STAT3 in cervical intraepithelial neoplasia
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Figure 1. Scoring systems for signal transducer and activator of transcription 3 (STAT3) (A–D) and Ki-67 (E–H) immunostaining.
Arrows indicate positive cells (original magnification, 200×).
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Table 1. Nuclear expression of signal transducer and activator of transcription 3 (STAT3) and Ki-67 in normal cervix
(NC), cervical intraepithelial neoplasia (CIN), and cervical squamous cell carcinoma (SCC)
NC (n = 10) CIN 1 (n = 20) CIN 2 (n = 10) CIN 3 (n = 26) SCC (n = 17) 
n (%) n (%) n (%) n (%) n (%)
STAT3 (%)
≤ 25 10 (100) 6 (30) 6 (60) 11 (42.3) 4 (23.5)
26–50 0 (0) 9 (45) 1 (10) 1 (3.9) 4 (23.5)
51–75 0 (0) 5 (25) 2 (20) 3 (11.5) 5 (29.4)
≥ 76 0 (0) 0 (0) 1 (10) 11 (42.3) 4 (23.5)
Ki-67 (%)
≤ 25 10 (95) 19 (95) 5 (50) 2 (7.7) 0 (0)
26–50 0 (0) 1 (5) 3 (30) 1 (3.9) 2 (11.8)
51–75 0 (0) 0 (0) 2 (20) 6 (23.1) 4 (23.5)
≥ 76 0 (0) 0 (0) 0 (0) 17 (65.4) 11 (64.7)
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Figure 2. (A, B) Signal transducer and activator of transcription 3 (STAT3) and (C, D) Ki-67 immunostaining in cervical intra-
epithelial neoplasia 3 and adjacent normal cervical epithelium. The dysplastic cells (arrows) show an intense nuclear staining of
STAT3 and Ki-67, while the adjacent normal squamous epithelium (arrowheads) shows relatively low nuclear STAT3 and Ki-67 staining
(original magnification: A and C, 40×; B and D, 200×).
Ki-67 staining was predominantly seen in the
nuclei of the squamous epithelial cells (Figure 1E–H).
As expected, with increased CIN histopathologic
grading, the Ki-67 nuclear expression was increased
and extended from the basal layer to the superficial
layer (Figure 3L–N). The majority of CIN 3 and SCC
cases exhibited strong Ki-67 expression (Table 1, Score
4), while none of the NC, CIN 1, and CIN 2 cases
expressed strong Ki-67 nuclear expression (Table 1).
Correlation of nuclear STAT3 expression
with the histopathologic grading of CIN
and Ki-67 expression
Although an intense nuclear STAT3 immunostaining
was present in the dysplastic cells from the basal layer
to the superficial layer (Figure 3), and a high nuclear
STAT3 expression (Score > 2) was observed in 25%,
30%, and 53.9% of CIN 1, 2, and 3 lesions (Table 2),
respectively, there was no statistically significant cor-
relation between nuclear STAT3 expression and CIN
lesion grade (Table 2, p = 0.112). In comparison with
Ki-67 expression, we found that in 31 cases with high
nuclear STAT3 expression, 20 and 11 cases revealed
high and low nuclear Ki-67 expressions, respectively.
STAT3 in cervical intraepithelial neoplasia
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Figure 3. (A–E) Ordinary hematoxylin and eosin (HE) staining; (F–J) immunostaining of signal transducer and activator of tran-
scription 3 (STAT3); and (K–O) Ki-67 in normal cervix (NC), cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma
(SCC) (original magnification, 200×).
Table 2. Correlation between nuclear signal transducer
and activator of transcription 3 (STAT3) expression and
cervical intraepithelial neoplasia (CIN) lesion grade
Lesion n
High STAT3 
p*expression (n = 22)
n (%)
CIN 1 20 5 (25) 0.112
CIN 2 10 3 (30)
CIN 3 26 14 (53.9)
*χ2 test.
While in 52 cases with low STAT3 expression, 20 and
32 cases revealed high and low Ki-67 expressions,
respectively. Intriguingly, nuclear STAT3 expression
was significantly correlated with Ki-67 expression in
CIN (p = 0.025).
DISCUSSION
It has been demonstrated that introduction of STAT3
small interfering RNA (siRNA) into SCC cells leads 
to an inhibition of tumor growth, and STAT3 siRNA-
transfected SCC cells had an impaired tumor growth 
in nude mice [23], implicating that an altered STAT3
expression may play an important role in cervical 
carcinogenesis. Consistently, in the present study, 
we also found that nuclear STAT3 expression was
increased along with CIN lesion grade (Tables 1 and 2),
although not reaching statistical significance (Table 2,
p = 0.112). Intriguingly, nuclear STAT3 expression was
significantly associated with nuclear Ki-67 expression
in CIN (p = 0.025). Therefore, we suggest that an
altered STAT3 expression might contribute to cervical
cancer development through its association with cell
proliferation.
CIN may be unchanged, regress to normal or to a
lesser grade of CIN, or progress to a higher grade of
CIN or invasive carcinoma [24]. In Figure 2, we show
that the CIN lesions expressed a higher STAT3 nuclear
expression than the adjacent normal cervical epithe-
lium as well as the comparative NC, although no sta-
tistically significant correlation was observed between
nuclear STAT3 expression and CIN lesion grade
(Table 2, p = 0.112). These results suggest that nuclear
STAT3 expression, possibly activated STAT3, may be
involved but does not play a critical role, at least in
CIN development. Intriguingly, we found that the
positive rate of squamous epithelial cells with strong
STAT3 nuclear immunostaining increased from CIN 1
to CIN 3, but decreased in SCC lesions (Table 1), sug-
gesting that an altered subcellular location of STAT3
may be an early alteration in cervical carcinogenesis as
observed in SCC of the head and neck [25]. In addi-
tion, although we have previously demonstrated that
the expression of phospho-STAT3 at serine residue 727
in CIN was significantly correlated with CIN lesion
grade and cell proliferation [26], the expression of
phospho-STAT3 (ser727) also decreased in stage Ib
SCC as compared to CIN 3 (data not shown), implying
that other factors or mechanisms may be involved in
the transition from CIN to cervical cancer; this  requires
further investigation.
In conclusion, our results indicate that the nuclear
expression of STAT3 might partially imply a higher
cell proliferation index but may not have a direct con-
tribution to the progression of CIN. In addition, an
altered STAT3 expression may be involved merely in
the early events of cervical cancer development.
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